Potential Senate Flip May Increase 340B Scrutiny, But Congressional 340B Action Unlikely in 2024, Say 340B Advocate, Drug Industry Analyst

Michael McCaughan, co-founder of Provision Policy, spoke about drug pricing policy at the 340B Coalition Winter Conference.
Congress is unlikely to act on 340B in 2024, but a potential flip of the U.S. Senate could lead to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Tennessee Bills Introduced to Regulate 340B Funding for Certain STD Clinics

Companion bills recently introduced in the Tennessee state house and senate would add regulations for 340B in-kind funding.
Tennessee state lawmakers have introduced companion bills that would require sexually transmitted disease (STD) clinics to enter into a contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AIDS Group Holds Protest Against NACHC-PhRMA Partnership

The AIDS Healthcare Foundation staged a protest over ASAP 340B, an alliance between community health centers and the drug industry, at the 340B Coalition Winter Conference.
As many attendees gathered for lunch outside at the 340B Coalition Winter Conference in San Diego on Tuesday, the AIDS [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Hospital Critics Ramp Up Efforts on Capitol Hill and in Media

ASAP 340B is one of multiple critics of hospital participation in 340B to recently increase lobbying and media efforts, including an online advertising campaign pictured above.
Critics of hospital participation in the 340B discount drug program are ramping up efforts, as a bipartisan group of senators [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Former Sen. Cassidy Aide, Trump Administration Executive Criticizes Requiring More Hospital 340B Reporting

Brenda Destro, a former aide to a Republican senator and HHS official, recently wrote an op-ed that criticized hospital 340B transparency legislation.
A former Trump administration Health and Human Service Department (HHS) executive and adviser to Sen. Bill Cassidy (R-LA) published a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Genesis Decision Expected to Increase 340B Scripts, Provider-Owned Pharmacies, Says Contractor to Drug Manufacturers and Former Apexus Staffer

Gavin Magaha, senior director of innovation at Kalderos and a former Apexus executive, said a recent judicial ruling on the 340B patient definition could increase the number of 340B patients and provider-owned pharmacies.
The ruling in a recent, high-profile 340B patient definition case will likely result in providers increasing the number of patients [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Hospitals Had Largest Markups of High-Cost Infused Drugs: Study

A New England Journal of Medicine study found that 340B hospitals had larger price markups than other hospitals or physician practices for certain high-cost infusion drugs.
340B hospitals had larger price markups than other hospitals or physician practices for 57 high-cost infusion drugs, according to a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

GSK, Vertex Offer Refunds to 340B Providers

GSK headquarters
GSK was one of two drugmakers to issue refunds to 340B covered entities, according to notices posted on a government regulatory site.
Drugmakers GlaxoSmithKline and Vertex Pharmaceuticals will offer refunds to 340B providers related to the purchases of several of their high-earning [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Exclusive

Genesis CEO Praises Court Decision, Blasts HRSA, NACHC, State Primary Care Association

Tony Megna, CEO and general counsel of Genesis Healthcare, shared his first public comments with 340B Report on a key 340B court decision.
In his first public comments since a key federal court decision on the 340B patient definition, the leader of a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Arkansas Looks to Amend Temporary Contract Pharmacy Agreement with Novo Nordisk

Arkansas Insurance Department office sign
The Arkansas Insurance Department will imminently enforce a state 340B contract pharmacy law following a key federal appeals court decision.
After hospitals in Arkansas raised concerns over details of an agreement by Novo Nordisk to temporarily loosen contract pharmacy restrictions, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live